BCL3 and neoplasm: Patients with p53mut tumours expressing high levels of Bcl3 showed significantly reduced RFS (n = 99, p = 0.0093) (Figure 5A), while no difference was observed in those with p53wt tumours (n = 144, p = 0.95) (Figure 5B).